Join the Lung Cancer Policy Network on 3 June for a webinar exploring how to build the economic case for lung cancer screening programmes. Our informative session will feature a panel of global experts, who will share insights on the critical aspects of economic evaluation needed to drive policy commitment and secure funding.
While clinical evidence for low-dose computed tomography (LDCT) screening is extensive, ensuring its wider implementation requires political and financial support. The ability to present evidence of cost-effectiveness and assess programme costs is key to achieving this.
Economic evaluations play a crucial role in supporting informed decision-making and ensuring the long-term sustainability of screening programmes. By demonstrating the cost-effectiveness of LDCT screening, these evaluations can optimise resource allocation and plan for equitable access.
The webinar – designed for clinicians, screening leads and implementation researchers – will cover the principles of robust economic evaluation and explain why it is vital to securing policy commitment. Case studies from around the world will spotlight successful strategies for building an economic case for screening programmes.
Attendees will have the opportunity to ask the panellists questions during a live Q&A session. Speakers will be announced soon.
We hope you can join us.
Recent news
News
England’s lung cancer screening programme: lessons from a national roll-out
A new article in Nature Medicine presents findings from the first five years of the NHS screening programme for lung cancer in England, and the results are striking.
News
Reflections from LuCE’s inaugural conference
Last month, the Network attended the inaugural Lung Cancer Europe conference in Vienna, which focused on the power of co‑creation in advocacy.
Blog
Lung cancer: the looming economic crisis governments can’t ignore
Lung cancer carries a heavy cost – not only for the people diagnosed, but for health systems and economies alike.